Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma

Multidisciplinary guidelines for management of invasive breast carcinoma from the American College of Radiology, the American College of Surgeons, the College of American Pathology, and the Society of Surgical Oncology have been updated to reflect the continuing advances in the diagnosis and treatment of invasive breast cancer. The guidelines provide a framework for clinical decision‐making for patients with invasive breast carcinoma based on review of relevant literature and include information on patient selection and evaluation, technical aspects of surgical treatment, techniques of irradiation, and follow‐up care.

[1]  H. Johansson,et al.  A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast‐conserving surgery , 1998, Cancer.

[2]  A. Hanlon,et al.  Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. , 1999, International journal of radiation oncology, biology, physics.

[3]  S E Harms,et al.  Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging , 1996, Cancer.

[4]  G. Noël,et al.  [Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17]. , 1999, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[5]  C. Carver,et al.  Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Luini,et al.  Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. , 1993, The New England journal of medicine.

[7]  C. Redmond,et al.  Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Catherine C. Park,et al.  The relationship between pathologic margin status and outcome after breast-conserving therapy , 1998 .

[9]  J. Jacquemier,et al.  Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy , 1990, Cancer.

[10]  D. Schultz,et al.  Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. , 1999, International journal of radiation oncology, biology, physics.

[11]  D. Dershaw,et al.  Mammography in patients with breast cancer treated by breast conservation (lumpectomy with or without radiation) , 1995, AJR. American journal of roentgenology.

[12]  F. Holmes,et al.  Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. , 1989, International journal of radiation oncology, biology, physics.

[13]  David C. Smith,et al.  Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial , 1996, The Lancet.

[14]  Christian Carrie,et al.  Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. , 1997 .

[15]  A. Luini,et al.  Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. , 1990, Annals of surgery.

[16]  E. Mendelson Evaluation of the postoperative breast. , 1992, Radiologic clinics of North America.

[17]  L. Tabár,et al.  10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  R. Arriagada,et al.  Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (institut gustave roussy 1970–1982) , 1995, Cancer.

[19]  R. Arriagada,et al.  Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A P Forrest,et al.  Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. , 1996, Lancet.

[21]  I. Fentiman,et al.  Conservative treatment of early breast cancer. , 1986, British journal of hospital medicine.

[22]  R. Schmidt,et al.  Patient selection for breast conservation therapy with magnification mammography. , 1995, Surgery.

[23]  H. Bartelink,et al.  The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. , 1999, International journal of radiation oncology, biology, physics.

[24]  J. Jacquemier,et al.  Local recurrence after breast‐conserving surgery and radiotherapy. Frequency, time course, and prognosis , 1989, Cancer.

[25]  D. Schultz,et al.  Outcome of conservative therapy for invasive breast cancer by histologic subtype. , 1992, International journal of radiation oncology, biology, physics.

[26]  Allan Tucker,et al.  Local Failure and Margin Status in Early‐Stage Breast Carcinoma Treated with Conservation Surgery and Radiation Therapy , 1993, Annals of surgery.

[27]  J. Connolly,et al.  Updated protocol for the examination of specimens from patients with carcinomas of the breast. Cancer Committee. , 2000, Archives of pathology & laboratory medicine.

[28]  J. Gazet,et al.  The importance of the resection margin in conservative surgery for breast cancer. , 1996, European Journal of Surgical Oncology.

[29]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[30]  C. Perez,et al.  Age as a prognostic factor for breast and regional nodal recurrence following breast conserving surgery and irradiation in stage I and II breast cancer. , 1993, International journal of radiation oncology, biology, physics.

[31]  J. Hogg Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.

[32]  M D Schnall,et al.  Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. , 1995, Radiology.

[33]  I. Gage,et al.  Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. , 1996, Cancer.

[34]  J. Costantino,et al.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  C. Perez,et al.  Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison. , 1996, International journal of radiation oncology, biology, physics.

[36]  A. Luini,et al.  Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. , 1986, European journal of cancer & clinical oncology.

[37]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[38]  J. Hendriks,et al.  Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ , 1990, The Lancet.

[39]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[40]  J. Vilcoq,et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.

[41]  A. Luini,et al.  Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. , 1995, European journal of cancer.

[42]  Jay R. Harris,et al.  Breast imaging. A critical aspect of breast conserving treatment , 1990, Cancer.

[43]  D. Fischer,et al.  Conservative surgery with radiation therapy in clinical stage I and II breast cancer. Results of a 20-year experience. , 1989, Archives of surgery.

[44]  K. McMasters,et al.  Defining the Optimal Surgeon Experience for Breast Cancer Sentinel Lymph Node Biopsy: A Model for Implementation of New Surgical Techniques , 2001, Annals of surgery.

[45]  R. Rubens,et al.  Breast Cancer Treatment. A Comprehensive Guide to Management , 1993, British Journal of Cancer.

[46]  Ronin,et al.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, The New England journal of medicine.

[47]  I. Gage,et al.  Pathologic margin involvement and the risk of recurrence in patients treated with breast‐conserving therapy , 1996 .

[48]  J. Kurtz,et al.  The second ten years: long-term risks of breast conservation in early breast cancer. , 1987, International journal of radiation oncology, biology, physics.

[49]  R Coquard,et al.  Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  S. Singletary,et al.  US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy. , 1999, Radiology.

[51]  C. Lewis,et al.  Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[52]  A. Recht,et al.  Mammographic detection of recurrent cancer in the irradiated breast. , 1987, AJR. American journal of roentgenology.

[53]  J. de Haes,et al.  The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  D. Berg,et al.  Boost irradiation of breast carcinoma: teletherapy vs. brachytherapy. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[56]  M. Gillin,et al.  Dose to the cardiac vascular and conduction systems in primary breast irradiation. , 1989, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[57]  J. Peterse,et al.  Impact of a boost dose of 16 GY on the local control and cosmesis in patients with early breast cancer: The EORTC ‘boost versus no boost’ trial , 2000 .

[58]  J. Dunn,et al.  16. The role of radiotherapy in early breast cancer (stage I). A West Midlands Breast Group prospective randomized collaborative study (BR 3002). , 1995 .

[59]  J. Mazeron,et al.  Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer--a twenty three year experience. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[60]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[61]  A. Hart,et al.  Risk factors in breast-conservation therapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  A. Rosenberg,et al.  Ten‐year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy , 1995, Cancer.

[63]  H. Bartelink,et al.  Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. , 1992, European journal of cancer.

[64]  F. Ames,et al.  Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer , 1989, Cancer.

[65]  R. Matter,et al.  Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease , 1991, Cancer.

[66]  D. Wickerham,et al.  Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  L. Belghiti,et al.  Prognostic factors in breast cancer , 2002 .

[68]  T. Whelan,et al.  Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update , 1996 .

[69]  S J Schnitt,et al.  The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy , 1994, Cancer.

[70]  A. Rademaker,et al.  Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. , 1999, Surgery.

[71]  J. Abrams,et al.  Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer. , 1995, Journal of the National Cancer Institute.

[72]  L. Rutqvist,et al.  Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. , 1996, International journal of radiation oncology, biology, physics.

[73]  A. Luini,et al.  Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute Trials , 2004, World Journal of Surgery.

[74]  S. Jeffrey,et al.  The importance of the lumpectomy surgical margin status in long term results of breast conservation , 1995, Cancer.

[75]  J. Peacock,et al.  Importance of margin status in outcome of breast-conserving surgery for carcinoma. , 1994, Surgery.

[76]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  R W Raven,et al.  The british association of surgical oncology , 1973, Annals of the Royal College of Surgeons of England.

[78]  J. Kurtz Which Patients Don't Need a Tumor-Bed Boost after Whole-Breast Radiotherapy? , 2001, Strahlentherapie und Onkologie.

[79]  F. Vicini,et al.  Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. , 1991, International journal of radiation oncology, biology, physics.

[80]  D. Schultz,et al.  Ten year results of conservative surgery and irradiation for stage I and II breast cancer. , 1991, International journal of radiation oncology, biology, physics.

[81]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[82]  J. Manola,et al.  Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  E van der Schueren,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2001, Journal of the National Cancer Institute.

[84]  Anthony Howell,et al.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. , 1995, The New England journal of medicine.

[85]  K Vajda,et al.  [Prognostic factors in breast cancer]. , 1998, Orvosi hetilap.

[86]  F. Vicini,et al.  Long term results with breast‐conserving therapy for patients with early stage breast carcinoma in a community hospital setting , 1998, Cancer.

[87]  D. Reintgen,et al.  Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. , 2001, Journal of the American College of Surgeons.

[88]  I. Gage,et al.  Long-term outcome following breast-conserving surgery and radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[89]  M. Ganott,et al.  The mammographic features of the postlumpectomy, postirradiation breast. , 1989, Radiographics : a review publication of the Radiological Society of North America, Inc.

[90]  E. Zubizarreta,et al.  Breast conservation treatment of early stage breast cancer: patterns of failure. , 1995, International journal of radiation oncology, biology, physics.

[91]  I. Lax,et al.  Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. , 1992, International journal of radiation oncology, biology, physics.

[92]  D. Wazer,et al.  Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. , 1998, International journal of radiation oncology, biology, physics.

[93]  H. Mouridsen,et al.  Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. , 1992, Journal of the National Cancer Institute. Monographs.

[94]  V. Bardou,et al.  Positive margins after conservative treatments impacts local control and possibly survival in node-negative breast cancer , 1998 .

[95]  D. Dershaw,et al.  Differentiation of benign and malignant local tumor recurrence after lumpectomy. , 1990, AJR. American journal of roentgenology.

[96]  B Fisher,et al.  Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. , 1996, Journal of the National Cancer Institute.

[97]  R. Clark,et al.  Breast cancer: a 21 year experience with conservative surgery and radiation. , 1982, International journal of radiation oncology, biology, physics.

[98]  J. Vilcoq,et al.  Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results. , 1989, European journal of cancer & clinical oncology.

[99]  P Okunieff,et al.  Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. , 1995, The New England journal of medicine.